516
Views
6
CrossRef citations to date
0
Altmetric
Research Articles

Clinical and laboratory findings following transplantation of allogeneic adipose-derived mesenchymal stromal cells in knee osteoarthritis, a brief report

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , , , , & ORCID Icon show all
Pages 663-674 | Received 01 Dec 2021, Accepted 03 May 2022, Published online: 20 Jul 2022

References

  • Testa G, Giardina SMC, Culmone A, Vescio A, Turchetta M, Cannavò S Pavone V. Intra-Articular injections in knee osteoarthritis: a review of literature. J Funct Morphol Kinesiol. 2021;6(1): 15. doi:10.3390/jfmk6010015.
  • Shah K, Zhao AG Sumer H. New approaches to treat osteoarthritis with mesenchymal stem cells. Stem Cells Int. 2018;2018: 1–9. doi:10.1155/2018/5373294.
  • Deshpande BR, Katz JN, Solomon DH, Yelin EH, Hunter DJ, Messier SP, Suter LG Losina E. Number of persons with symptomatic knee osteoarthritis in the US: impact of race and ethnicity, age, sex, and obesity. Arthritis Care Res. 2016;68(12): 1743–1750. doi:10.1002/acr.22897.
  • Sasaki E, Ota S, Chiba D, Kimura Y, Sasaki S, Yamamoto Y, Tsuda E, Nakaji S Ishibashi Y. Early knee osteoarthritis prevalence is highest among middle-aged adult females with obesity based on new set of diagnostic criteria from a large sample cohort study in the Japanese general population. Knee Surg Sports Traumatol Arthrosc. 2020;28(3): 984–994. doi:10.1007/s00167-019-05614-z.
  • Driban JB, Harkey MS, Barbe MF, Ward RJ, MacKay JW, Davis JE, Lu B, Price LL, Eaton CB Lo GH, McAlindon TE. Risk factors and the natural history of accelerated knee osteoarthritis: a narrative review. BMC Musculoskelet Disord. 2020;21(1): 1–11. doi:10.1186/s12891-020-03367-2.
  • Lu Y, Zhang W, Wang J, Yang G, Yin S, Tang T, Yu C Jiang X. Recent advances in cell sheet technology for bone and cartilage regeneration: from preparation to application. Int J Oral Sci. 2019;11(2): 1–13. doi:10.1038/s41368-019-0050-5.
  • Zhou Z, Wu W, Fang J Yin J. Polymer-Based porous microcarriers as cell delivery systems for applications in bone and cartilage tissue engineering. Int Mater Rev. 2021;66(2): 77–113. doi:10.1080/09506608.2020.1724705.
  • Rahmani Del Bakhshayesh A, Babaie S, Tayefi Nasrabadi H, Asadi N, Akbarzadeh A Abedelahi A. An overview of various treatment strategies, especially tissue engineering for damaged articular cartilage. Artif Cells Nanomed Biotechnol. 2020;48(1): 1089–1104. doi:10.1080/21691401.2020.1809439.
  • Urlić I Ivković A. Cell sources for cartilage repair—biological and clinical perspective. Cells. 2021;10(9): 2496. doi:10.3390/cells10092496.
  • Musiał-Wysocka A, Kot M Majka M. The pros and cons of mesenchymal stem cell-based therapies. Cell Transplant. 2019;28(7): 801–812. doi:10.1177/0963689719837897.
  • Macrin D, Joseph JP, Pillai AA Devi A. Eminent sources of adult mesenchymal stem cells and their therapeutic imminence. Stem Cell Rev Rep. 2017;13(6): 741–756. doi:10.1007/s12015-017-9759-8.
  • Dabrowska S, Andrzejewska A, Janowski M Lukomska B. Immunomodulatory and regenerative effects of mesenchymal stem cells and extracellular vesicles: therapeutic outlook for inflammatory and degenerative diseases. Front Immunol. 2021;11: 3809. doi:10.3389/fimmu.2020.591065.
  • Vasiliadis AV Galanis N. Effectiveness of ad-MSCs injections for the treatment of knee osteoarthritis: analysis of the current literature. J Stem Cells Regen Med. 2020;16(1): 3.
  • Lam AT, Reuveny S Oh SK. Human mesenchymal stem cell therapy for cartilage repair: review on isolation, expansion, and constructs. Stem Cell Res. 2020;44(101738): 101738. doi:10.1016/j.scr.2020.101738.
  • McIntyre JA, Jones IA, Han B Vangsness CT. Intra-Articular mesenchymal stem cell therapy for the human joint: a systematic review. Am J Sports Med. 2018;46(14): 3550–3563. doi:10.1177/0363546517735844.
  • Burrow KL, Hoyland JA Richardson SM. Human adipose-derived stem cells exhibit enhanced proliferative capacity and retain multipotency longer than donor-matched bone marrow mesenchymal stem cells during expansion in vitro. Stem Cells Int. 2017;2017: 1–15. doi:10.1155/2017/2541275.
  • Han X, Yang B, Zou F Sun J. Clinical therapeutic efficacy of mesenchymal stem cells derived from adipose or bone marrow for knee osteoarthritis: a meta-analysis of randomized controlled trials. J Comp Eff Res. 2020;9(5): 361–374. doi:10.2217/cer-2019-0187.
  • Pers Y-M, Quentin J, Feirreira R, Espinoza F, Abdellaoui N, Erkilic N, Cren M, Dufourcq-Lopez E, Pullig O, Nöth U, Jorgensen C Louis-Plence P. Injection of adipose-derived stromal cells in the knee of patients with severe osteoarthritis has a systemic effect and promotes an anti-inflammatory phenotype of circulating immune cells. Theranostics. 2018;8(20): 5519. doi:10.7150/thno.27674.
  • Wang Y, Shimmin A, Ghosh P, Marks P, Linklater J, Connell D, Hall S, Skerrett D, Itescu S Cicuttini FM. Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: a controlled double-blind randomised trial. Arthritis Res Ther. 2017;19(1): 180. doi:10.1186/s13075-017-1391-0.
  • Park YB, Ha CW, Lee CH, Yoon YC Park YG. Cartilage regeneration in osteoarthritic patients by a composite of allogeneic umbilical cord blood‐derived mesenchymal stem cells and hyaluronate hydrogel: results from a clinical trial for safety and proof‐of‐concept with 7 years of extended follow‐up. Stem Cells Trans Med. 2017;6(2): 613–621. doi:10.5966/sctm.2016-0157.
  • Soltani SK, Forogh B, Ahmadbeigi N, Kharazi HH, Fallahzadeh K, Kashani L, Karami M, Kheyrollah Y Vasei M. Safety and efficacy of allogenic placental mesenchymal stem cells for treating knee osteoarthritis: a pilot study. Cytotherapy. 2019;21(1): 54–63. doi:10.1016/j.jcyt.2018.11.003.
  • Zhao X, Ruan J, Tang H, Li J, Shi Y, Li M, Li S, Xu C, Lu Q Dai C. Multi-Compositional MRI evaluation of repair cartilage in knee osteoarthritis with treatment of allogeneic human adipose-derived mesenchymal progenitor cells. Stem Cell Res Ther. 2019;10(1): 308. doi:10.1186/s13287-019-1406-7.
  • Lu L, Dai C, Du H, Li S, Ye P, Zhang L, Wang X, Song Y, Togashi R Vangsness CT, Bao C. Intra-Articular injections of allogeneic human adipose-derived mesenchymal progenitor cells in patients with symptomatic bilateral knee osteoarthritis: a phase I pilot study. Regen Med. 2020;15(5): 1625–1636. doi:10.2217/rme-2019-0106.
  • Sadri B, Sh N, Hossein-Khannazer N, Mohammadi J Vosough M. Current and novel theranostic modalities for knee osteoarthritis. Сеченовский Вестник. 2021;12(3): 17–30.
  • Ha C-W, Park Y-B, Kim SH Lee HJ. Intra-Articular mesenchymal stem cells in osteoarthritis of the knee: a systematic review of clinical outcomes and evidence of cartilage repair. Arthroscopy. 2019;35(1): 277–288. doi:10.1016/j.arthro.2018.07.028.
  • Dai W, Leng X, Wang J, Shi Z, Cheng J, Hu X Ao Y. Intra-Articular mesenchymal stromal cell injections are no different from placebo in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Arthroscopic. 2021;37(1): 340–358. doi:10.1016/j.arthro.2020.10.016.
  • Xiang X-N, Zhu S-Y, H-C H, Yu X, Xu Y He CQ. Mesenchymal stromal cell-based therapy for cartilage regeneration in knee osteoarthritis. Stem Cell Res Ther. 2022;13(1): 1–20. doi:10.1186/s13287-021-02689-9.
  • Alonso-Goulart V, Ferreira LB, Duarte CA, de Lima IL, Ferreira ER, de Oliveira BC, Vargas LN, de Moraes DD, Silva IBB de Oliveira Faria R, Souza AGD, Castro-Filice LDS. Mesenchymal stem cells from human adipose tissue and bone repair: a literature review. Biotechnol Res Innov. 2018;2(1): 74–80. doi:10.1016/j.biori.2017.10.005.
  • Estrada E, Décima JL, Rodríguez M, Di Tomaso M Roberti J. Patient-Reported outcomes after platelet-rich plasma, bone marrow aspirate, and adipose-derived mesenchymal stem cell injections for symptomatic knee osteoarthritis. Clin Med Insights Arthritis Musculoskelet Disord. 2020;13: 1179544120931086. doi:10.1177/1179544120931086.
  • Mautner K, Carr D, Whitley J Bowers R. Allogeneic versus autologous injectable mesenchymal stem cells for knee osteoarthritis: Review and current status. Tech Orthop. 2019;34(4): 244–256. doi:10.1097/BTO.0000000000000357.
  • Weiss ARR Dahlke MH Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead mscs. Front immunol. 2019;10: 1191.
  • Vega A, Martín-Ferrero MA, Del Canto F, Alberca M, García V, Munar A, Orozco L, Soler R, Fuertes JJ, Huguet M, Sánchez A García-Sancho J. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial. Transplantation. 2015;99(8): 1681–1690. doi:10.1097/TP.0000000000000678.
  • Song Y, Du H, Dai C, Zhang L, Li S, Hunter DJ, Lu L Bao C. Human adipose-derived mesenchymal stem cells for osteoarthritis: a pilot study with long-term follow-up and repeated injections. Regen Med. 2018;13(3): 295–307. doi:10.2217/rme-2017-0152.
  • Cabon Q, Febre M, Gomez N, Cachon T, Pillard P, Carozzo C, Saulnier N, Robert C, Livet V Rakic R, Plantier N, Saas P, Maddens S, Viguier E. Long-Term safety and efficacy of single or repeated intra-articular injection of allogeneic neonatal mesenchymal stromal cells for managing pain and lameness in moderate to severe canine osteoarthritis without anti-inflammatory pharmacological support: pilot clinical study. Front Vet Sci. 2019;6:10.
  • Pers Y-M, Rackwitz L, Ferreira R, Pullig O, Delfour C, Barry F, Sensebe L, Casteilla L, Fleury S, Bourin P, Noël D, Canovas F, Cyteval C, Lisignoli G, Schrauth J, Haddad D, Domergue S, Noeth U Jorgensen C. Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase I dose-escalation trial. Stem Cells Trans Med. 2016;5(7): 847–856. doi:10.5966/sctm.2015-0245.
  • Jo CH, Chai JW, Jeong EC, Oh S, Shin JS, Shim H Yoon KS. Intra-Articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a 2-year follow-up study. Am J Sports Med. 2017;45(12): 2774–2783. doi:10.1177/0363546517716641.
  • Sekiya I, Katano H, Mizuno M, Koga H, Masumoto J, Tomita M Ozeki N. Alterations in cartilage quantification before and after injections of mesenchymal stem cells into osteoarthritic knees. Sci Rep. 2021;11(1): 1–14. doi:10.1038/s41598-021-93462-8.
  • Jo CH, Lee YG, Shin WH, Kim H, Chai JW, Jeong EC, Kim JE, Shim H, Shin JS Shin IS, Ra JC, Oh S, Yoon KS. Intra‐articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof‐of‐concept clinical trial. Stem Cells. 2014;32(5): 1254–1266. doi:10.1002/stem.1634.
  • Stannus O, Jones G, Cicuttini F, Parameswaran V, Quinn S, Burgess J Ding C. Circulating levels of il-6 and tnf-α are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Ostenarthr Cartil. 2010;18(11): 1441–1447. doi:10.1016/j.joca.2010.08.016.
  • Li J, Shao Q, Zhu X Sun G. Efficacy of autologous bone marrow mesenchymal stem cells in the treatment of knee osteoarthritis and their effects on the expression of serum tnf-α and il-6. J Musculoskelet Neuronal Interact. 2020;20(1): 128.
  • Potere N, Batticciotto A, Vecchié A, Porreca E, Cappelli A, Abbate A, Dentali F Bonaventura A. The role of il-6 and il-6 blockade in COVID-19. Expert Rev Clin Immunol. 2021;17(6): 601–618. doi:10.1080/1744666X.2021.1919086.
  • Haddad R Saldanha-Araujo F. Mechanisms of t-cell immunosuppression by mesenchymal stromal cells: what do we know so far? Biomed Res Int. 2014;2014: 1–14. doi:10.1155/2014/216806.
  • Jiao Q, Wei L, Chen C, Li P, Wang X, Li Y, Guo L, Zhang C Wei X. Cartilage oligomeric matrix protein and hyaluronic acid are sensitive serum biomarkers for early cartilage lesions in the knee joint. Biomarkers. 2016;21(2): 146–151. doi:10.3109/1354750X.2015.1118547.
  • Chahal J, Gómez-Aristizábal A, Shestopaloff K, Bhatt S, Chaboureau A, Fazio A, Chisholm J, Weston A, Chiovitti J Keating A, Kapoor M, Ogilvie-Harris DJ, Syed KA, Gandhi R, Mahomed NN, Marshall KW, Sussman MS, Naraghi AM, Viswanathan S. Bone marrow mesenchymal stromal cell treatment in patients with osteoarthritis results in overall improvement in pain and symptoms and reduces synovial inflammation. Stem Cells Transl Med. 2019;8(8): 746–757. doi:10.1002/sctm.18-0183.
  • Bannuru RR, McAlindon TE, Sullivan MC, Wong JB, Kent DM Schmid CH. Effectiveness and implications of alternative placebo treatments: a systematic review and network meta-analysis of osteoarthritis trials. Ann Intern Med. 2015;163(5): 365–372. doi:10.7326/M15-0623.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.